Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patients

Cell-free DNA (cfDNA) is described to mirror intratumoral heterogeneity and gives insight about clonal evolution for improved therapeutic decisions. We sequenced cfDNA of a hormone receptor-positive, HER2-negative metastatic breast cancer (MBC) cohort with a high coverage to examine the prevalence a...

Descripción completa

Detalles Bibliográficos
Autores principales: Keup, Corinna, Benyaa, Karim, Hauch, Siegfried, Sprenger-Haussels, Markus, Tewes, Mitra, Mach, Pawel, Bittner, Ann-Kathrin, Kimmig, Rainer, Hahn, Peter, Kasimir-Bauer, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010653/
https://www.ncbi.nlm.nih.gov/pubmed/31254045
http://dx.doi.org/10.1007/s00018-019-03189-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010653/
https://www.ncbi.nlm.nih.gov/pubmed/31254045
http://dx.doi.org/10.1007/s00018-019-03189-z

Ejemplares similares